IRIS
LUCIANO, NICOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 856
NA - Nord America 636
EU - Europa 186
SA - Sud America 160
AF - Africa 16
Totale 1.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 604
SG - Singapore 548
CN - Cina 140
BR - Brasile 132
VN - Vietnam 85
FR - Francia 34
IT - Italia 31
HK - Hong Kong 27
DE - Germania 24
CA - Canada 15
GB - Regno Unito 14
MX - Messico 13
PL - Polonia 12
AR - Argentina 11
FI - Finlandia 11
IN - India 11
RU - Federazione Russa 9
SE - Svezia 9
ES - Italia 8
GR - Grecia 8
ZA - Sudafrica 7
AT - Austria 5
IQ - Iraq 5
JP - Giappone 5
NL - Olanda 5
UZ - Uzbekistan 5
EC - Ecuador 4
ID - Indonesia 4
BD - Bangladesh 3
IE - Irlanda 3
KE - Kenya 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
SA - Arabia Saudita 2
TN - Tunisia 2
TR - Turchia 2
VE - Venezuela 2
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
TG - Togo 1
UA - Ucraina 1
Totale 1.854
Salva come PNG Salva come JPEG
Città #
Singapore 263
Ashburn 141
San Jose 117
The Dalles 88
Dallas 45
Beijing 42
Shanghai 41
Ho Chi Minh City 31
Hong Kong 27
Chandler 22
Hanoi 17
Los Angeles 15
São Paulo 15
Warsaw 12
Helsinki 11
New York 9
Stockholm 8
Da Nang 7
Milan 7
Santa Clara 7
Frankfurt am Main 6
Mexico City 6
Montreal 6
Naples 6
Amsterdam 5
Boardman 5
Düsseldorf 5
Paris 5
Rio de Janeiro 5
Springfield 5
Tashkent 5
Tokyo 5
Assago 4
Council Bluffs 4
Haiphong 4
Lauterbourg 4
Brasília 3
Brooklyn 3
Cape Town 3
Chennai 3
Chicago 3
Dublin 3
Falkenstein 3
Guarulhos 3
Nairobi 3
Portsmouth 3
San Francisco 3
Seattle 3
São Bernardo do Campo 3
Thái Bình 3
Americana 2
Aparecida de Goiânia 2
Asunción 2
Baku 2
Calgary 2
Campo Grande 2
Curitiba 2
Denver 2
Diadema 2
Duque de Caxias 2
Florence 2
Fort Worth 2
Guatapará 2
Houston 2
Hải Dương 2
Isidro Casanova 2
Johannesburg 2
Jundiaí 2
Lima 2
London 2
Manchester 2
Ninh Bình 2
Nuremberg 2
Perm 2
Salvador 2
Sassari 2
Toronto 2
Almaty 1
Almeirim Municipality 1
Alta Floresta 1
Alvorada 1
Ambato 1
Amman 1
Andrelândia 1
Ankara 1
Antakya 1
Aracaju 1
Araçuaí 1
Arequipa 1
Athens 1
Baghdad 1
Baie-D'Urfé 1
Ballwin 1
Baraúna 1
Barinas 1
Barking 1
Beirut 1
Bella Vista 1
Belo Horizonte 1
Ben Arous 1
Totale 1.124
Salva come PNG Salva come JPEG
Nome #
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 106
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 74
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 70
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 60
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 57
A clinical prediction rule for lymphoma development in primary Sjögren's syndrome 56
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 54
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 50
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 49
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 49
Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma 47
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study 47
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study 46
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review 45
Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome 44
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender 43
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 43
The need to ask for directions on the winding road of psoriatic arthritis 43
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study 43
Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature 42
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 41
Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes? 41
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 41
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 40
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 40
Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome 40
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study 40
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 39
Imaging in primary Sjögren's syndrome: the 'obsolete and the new' 39
One year in review 2015: Sjögren's syndrome 39
Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study 38
Myositis in primary Sjögren's syndrome: data from a multicentre cohort 37
Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: Consensual US-SG core items definition and reliability 36
One year in review 2017: novelties in the treatment of rheumatoid arthritis 36
Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases 36
High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease 35
Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis 35
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience 34
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome 33
One year in review 2018: novelties in the treatment of rheumatoid arthritis 33
Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjögren's syndrome (pSS) clinical trials? 32
Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritis 30
Salivary Gland Ultrasonography in Sjögren's Syndrome: Clinical Usefulness and Future Perspectives 28
Totale 1.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.135
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202352 0 2 4 9 3 6 0 10 11 4 1 2
2023/202435 5 1 6 2 1 7 2 2 0 3 1 5
2024/2025685 35 72 15 16 11 77 45 25 97 139 86 67
2025/20261.139 170 95 73 85 96 77 343 65 87 48 0 0
Totale 1.911